VA

Vivek Agarwal

Active Director Director DIN 02733073
DIN 02733073 First appointment Aug 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 2 historical roles
Total affiliations 7 Since Aug 2009
Shareholding value •••• Premium profile

About Vivek Agarwal

Data last updated:

Vivek Agarwal is a Director at Blue Print Pharmacy Private Limited (since 2019), Director at Allergimmuno Diagnostics Private Limited (since 2019) and Director at Manshya Agro Private Limited (since 2012), and holds 2 more current directorships. The companies operate in Pharma, Healthcare and Agriculture. The 2 current companies with reported revenue have a combined latest revenue of ₹23.42 Cr; the largest is Blue Print Pharmacy Private Limited at ₹17.83 Cr (FY 2025). Earlier, Vivek Agarwal was a Director at Sunrise Trademart Private Limited (2009) and Director at Shivam Gases (Enterprise) Private Limited (2013–2019).

DIN 02733073
Primary Designation Director
Industry Pharma
First Appointment 03 Aug 2009
Oldest Company Age 35 yrs
Largest company Blue Print Pharmacy Private Limited · ₹17.83 Cr (FY 2025)
Combined revenue ₹23.42 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Blue Print Pharmacy Private Limited U24100WB1991PTC052626
Director20 Aug 20191991₹17.83 Cr (FY 2025)Active
Director29 Mar 20192013₹5.59 Cr (FY 2025)Active
Manshya Agro Private Limited U01403WB2012PTC187055
Director10 Oct 20122012Active
Designated Partner15 Sep 20202018Active
Ikshita Agrotech Private Limited U01403WB2013PTC195317
Director03 Jul 20132013Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sunrise Trademart Private Limited U51109WB2007PTC116817
Director03 Aug 20092007₹15.54 Cr (FY 2024)Active
Director05 Jun 20132008₹86.6 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
3D Resturants Llp
Manshya Agro Private Limited
Ikshita Agrotech Private Limited
Blue Print Pharmacy Private Limited
Premium access

Shareholding and investment profile for Vivek Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vivek Agarwal

Vivek Agarwal currently holds 5 directorships: Blue Print Pharmacy Private Limited (Director, since 20 Aug 2019, revenue ₹17.83 Cr (FY 2025)); Allergimmuno Diagnostics Private Limited (Director, since 29 Mar 2019, revenue ₹5.59 Cr (FY 2025)); Manshya Agro Private Limited (Director, since 10 Oct 2012); 3D Resturants Llp (Designated Partner, since 15 Sep 2020); Ikshita Agrotech Private Limited (Director, since 03 Jul 2013).

Vivek Agarwal was first appointed on 03 Aug 2009 as Director at Sunrise Trademart Private Limited. The most recent appointment on record is 15 Sep 2020 at 3D Resturants Llp.

The 2 current companies of Vivek Agarwal that report revenue have a combined latest revenue of ₹23.42 Cr: Blue Print Pharmacy Private Limited ₹17.83 Cr (FY 2025); Allergimmuno Diagnostics Private Limited ₹5.59 Cr (FY 2025).

Vivek Agarwal held 2 earlier board appointments: Sunrise Trademart Private Limited (Director, 03 Aug 2009 to 11 Nov 2009); Shivam Gases (Enterprise) Private Limited (Director, 05 Jun 2013 to 21 Aug 2019).

The current boards of Vivek Agarwal's companies include Priya Agarwal (Blue Print Pharmacy Private Limited), Pratanu Biswas (Allergimmuno Diagnostics Private Limited), Rajorshi Chakraborty (Allergimmuno Diagnostics Private Limited), Pushpa Agarwal (Manshya Agro Private Limited), Suresh Kumar Agarwal (Manshya Agro Private Limited), Abhishek Agarwal (Ikshita Agrotech Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available